Link to this page
National Cancer Institute Thesaurus
Last uploaded:
February 23, 2024
Jump to:
Preferred Name | Fosaprepitant Dimeglumine | |
Synonyms |
FOSAPREPITANT DIMEGLUMINE Fosaprepitant Dimeglumine fosaprepitant dimeglumine Emend for Injection L-785,298 MK-0517 |
|
Definitions |
The dimeglumine salt form of fosaprepitant, the water-soluble, N-phosphorylated prodrug of aprepitant, with antiemetic activity. Upon intravenous administration and rapid conversion to aprepitant, this agent binds selectively to the human substance P/neurokinin 1 (NK1) receptors in the central nervous system (CNS). This inhibits receptor binding of the endogenous substance P and prevents substance P-induced emesis. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C72788 |
|
ALT_DEFINITION |
A drug used together with other drugs to prevent and control nausea and vomiting caused by cancer treatment. It is given in a vein. It is a type of antiemetic and a type of substance P/neurokinin 1 receptor antagonist.
|
|
CAS_Registry |
265121-04-8
|
|
CHEBI_ID |
CHEBI:64311
|
|
Chemical_Formula |
C23H22F7N4O6P.2C7H17NO5
|
|
code |
C72788
|
|
Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 |
|
Contributing_Source |
CTRP FDA
|
|
DEFINITION |
The dimeglumine salt form of fosaprepitant, the water-soluble, N-phosphorylated prodrug of aprepitant, with antiemetic activity. Upon intravenous administration and rapid conversion to aprepitant, this agent binds selectively to the human substance P/neurokinin 1 (NK1) receptors in the central nervous system (CNS). This inhibits receptor binding of the endogenous substance P and prevents substance P-induced emesis.
|
|
Display_Name |
Fosaprepitant Dimeglumine
|
|
FDA_UNII_Code |
D35FM8T64X
|
|
FULL_SYN |
FOSAPREPITANT DIMEGLUMINE Fosaprepitant Dimeglumine fosaprepitant dimeglumine Emend for Injection L-785,298 MK-0517
|
|
Has_Free_Acid_Or_Base_Form | ||
Has_Target | ||
label |
Fosaprepitant Dimeglumine
|
|
Legacy Concept Name |
Fosaprepitant_Dimeglumine
|
|
NCI_Drug_Dictionary_ID |
642614
|
|
PDQ_Closed_Trial_Search_ID |
642614
|
|
PDQ_Open_Trial_Search_ID |
642614
|
|
Preferred_Name |
Fosaprepitant Dimeglumine
|
|
prefixIRI |
Thesaurus:C72788
|
|
Semantic_Type |
Pharmacologic Substance
|
|
UMLS_CUI |
C2607622
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping